Replies to post #509409 on Anavex Life Sciences Corp (AVXL)

[frrol]

The hope is more accommodating rapporteurs in round 2 and a restrictive approval recommendation with a follow-up RCT requirement. It's a long shot, but worth taking while the company finally gets going with the FDA and other regulators like Missling said he was doing almost 2 years ago.